Trial Details
COMPLETEDBasic Information
| Clinical ID | c1358 |
|---|---|
| Identifier | NCT03662542 |
| Trial Title | A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Guselkumab Dose 1|DRUG: Guselkumab Dose 2|DRUG: Golimumab Dose 1|DRUG: Golimumab Dose 2|DRUG: Placebo |
Participant Information
| Sponsor | Janssen Research & Development, LLC |
|---|---|
| City | San Diego |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-11-20 |
|---|---|
| Primary Completion Date | 2020-12-01 |
| Completion Date | 2021-11-15 |